VIMTALABS Stock Overview
Provides contract research and testing services in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Vimta Labs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹832.65 |
| 52 Week High | ₹1,069.95 |
| 52 Week Low | ₹420.00 |
| Beta | 0.59 |
| 1 Month Change | -16.25% |
| 3 Month Change | 45.36% |
| 1 Year Change | 82.20% |
| 3 Year Change | 103.46% |
| 5 Year Change | 661.11% |
| Change since IPO | -8.35% |
Recent News & Updates
Recent updates
Vimta Labs Limited's (NSE:VIMTALABS) 30% Share Price Surge Not Quite Adding Up
Dec 24
Subdued Growth No Barrier To Vimta Labs Limited (NSE:VIMTALABS) With Shares Advancing 28%
Nov 09There's Reason For Concern Over Vimta Labs Limited's (NSE:VIMTALABS) Massive 31% Price Jump
Sep 06It Looks Like Shareholders Would Probably Approve Vimta Labs Limited's (NSE:VIMTALABS) CEO Compensation Package
Jul 12Vimta Labs (NSE:VIMTALABS) Seems To Use Debt Quite Sensibly
Jun 12Market Might Still Lack Some Conviction On Vimta Labs Limited (NSE:VIMTALABS) Even After 26% Share Price Boost
Apr 26It's A Story Of Risk Vs Reward With Vimta Labs Limited (NSE:VIMTALABS)
Jan 06If EPS Growth Is Important To You, Vimta Labs (NSE:VIMTALABS) Presents An Opportunity
Jul 14Vimta Labs (NSE:VIMTALABS) Has Announced A Dividend Of ₹2.00
Jun 03Vimta Labs' (NSE:VIMTALABS) Dividend Will Be ₹2.00
May 06A Look At The Intrinsic Value Of Vimta Labs Limited (NSE:VIMTALABS)
Dec 07Here's Why We Think Vimta Labs (NSE:VIMTALABS) Might Deserve Your Attention Today
Nov 06Vimta Labs (NSE:VIMTALABS) Is Due To Pay A Dividend Of ₹2.00
Jun 02Does Vimta Labs (NSE:VIMTALABS) Deserve A Spot On Your Watchlist?
Dec 06Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly
Oct 27We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Vimta Labs Limited's (NSE:VIMTALABS) CEO For Now
Jun 29Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?
Jun 19Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly
Mar 09Vimta Labs Limited's (NSE:VIMTALABS) Stock Is Going Strong: Have Financials A Role To Play?
Jan 20Shareholder Returns
| VIMTALABS | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -3.9% | -4.1% | -1.4% |
| 1Y | 82.2% | 39.9% | 5.8% |
Return vs Industry: VIMTALABS exceeded the Indian Life Sciences industry which returned 39.9% over the past year.
Return vs Market: VIMTALABS exceeded the Indian Market which returned 5.8% over the past year.
Price Volatility
| VIMTALABS volatility | |
|---|---|
| VIMTALABS Average Weekly Movement | 9.7% |
| Life Sciences Industry Average Movement | 7.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: VIMTALABS's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: VIMTALABS's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 1,428 | Harita Vasireddi | vimta.com |
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, central lab, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; a testing laboratory for water, alcoholic, and non-alcoholic beverages; and clinical diagnostic services to patients, clinicians, hospitals, and central lab services to support clinical research studies.
Vimta Labs Limited Fundamentals Summary
| VIMTALABS fundamental statistics | |
|---|---|
| Market cap | ₹18.51b |
| Earnings (TTM) | ₹545.93m |
| Revenue (TTM) | ₹3.53b |
33.9x
P/E Ratio5.2x
P/S RatioIs VIMTALABS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VIMTALABS income statement (TTM) | |
|---|---|
| Revenue | ₹3.53b |
| Cost of Revenue | ₹998.20m |
| Gross Profit | ₹2.53b |
| Other Expenses | ₹1.99b |
| Earnings | ₹545.93m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 24.58 |
| Gross Margin | 71.72% |
| Net Profit Margin | 15.47% |
| Debt/Equity Ratio | 3.4% |
How did VIMTALABS perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yield11%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 22:29 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vimta Labs Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rohit Bhat | Batlivala & Karani Securities India Pvt. Ltd. |
| Vijay Madunala | FirstCall Research |